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Abstract: The study’s purpose was to identify HIV, Black–White race, and birth country disparities
in retention in HIV care and HIV viral load (VL) suppression among Latinos, in 2015. Florida’s
surveillance data for Latinos diagnosed with HIV (2000–2014) were merged with American
Community Survey data. Multi-level (random effects) models were used to estimate adjusted
odds ratios (aOR) for non-retention in care and non-viral load suppression. Blacks and Whites
experienced similar odds of non–retention in care. Racial differences in VL suppression disappeared
after controlling for neighborhood factors. Compared to U.S.–born Latinos, those born in Mexico
(retention aOR 2.00, 95% CI 1.70–2.36; VL 1.85, 95% CI 1.57–2.17) and Central America (retention
aOR 1.33, 95% CI 1.16–1.53; VL 1.28, 95% CI 1.12–2.47) were at an increased risk after controlling for
individual and neighborhood factors. Among Central Americans, those born in Guatemala (retention
aOR 2.39, 95% CI 1.80–3.18; VL 2.20, 95% CI 1.66–2.92) and Honduras (retention aOR 1.39, 95% CI
1.13–1.72; VL 1.42, 95% CI 1.16–1.74) experienced the largest disparities, when compared to U.S.-born
Latinos. Disparities in care and treatment exist within the Latino population. Cultural and other
factors, unique to Latino Black-White racial and birth country subgroups, should be further studied
and considered for intervention.
Keywords: Latinos; racial disparities; birth country disparities; human immunodeficiency virus;
retention in HIV care; viral suppression
1. Introduction
Both the Joint United Nations Programme on HIV/AIDS and the United States (U.S.) National
HIV/AIDS Strategy, call for significant improvements in retention in HIV care and viral load
suppression among individuals with HIV, in order to end the national and worldwide HIV/AIDS
epidemic [1,2]. Poor retention in HIV care has been associated with delayed viral load suppression [3]
Int. J. Environ. Res. Public Health 2017, 14, 120; doi:10.3390/ijerph14020120 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2017, 14, 120 2 of 12
and increased risk of mortality [4]. Low-level viremia has been associated with improved immunologic
response [5], delayed time to opportunistic infection [6], and decreased risk of sexual HIV transmission [7].
In addition, the National HIV/AIDS Strategy aims to reduce HIV-related disparities and health
inequities [2]. A recent Centers for Disease Control and Prevention (CDC) study of 11 states and
the District of Columbia, suggests that the proportion of Hispanics/Latinos with HIV who are
consistently retained in care (49.5%) is higher than for non-Latino Whites (48.6%) and non-Latino
Blacks (37.7%) [8]. Furthermore, the proportion of Latinos in the US in care who are virally suppressed,
is reportedly similar to that of non-Latino Whites (31% vs. 32%, p-value 0.91). However, previous
studies by our group and others have shown significant disparities within racial and birth country
subgroups of Latinos when focusing on HIV risk [9], delayed HIV diagnosis [10–12], and survival
after HIV [10,13–15]. Only one study to date has examined retention in care among Latinos by country
of birth (or country of origin), but this research simply reported the findings for Latinos born in
Mexico and Central America, and small sample sizes precluded multivariate modeling or in-depth
analysis [16]. To our knowledge, no studies have examined viral suppression by country of birth,
or retention in care and viral suppression by race, among Latinos.
Furthermore, Latinos differ in socioeconomic status, with Black Latinos, and Mexican and
Central American Latinos, more likely to experience poverty, lower educational attainment,
and unemployment, than their White and U.S.-born counterparts [17,18]. These differences
in individual-level socioeconomic status likely create disparities in exposure to neighborhood
disadvantage. Low neighborhood socioeconomic status and neighborhood poverty have been
associated with high HIV rates [19,20], and low AIDS survival [21,22], and have been shown to partially
account for racial/ethnic disparities in HIV/AIDS survival [23,24], and antiretroviral initiation [24].
Given the vital individual and public health benefits of retention in care and viral suppression,
and the wide health and socioeconomic disparities previously reported, it is important to assess
whether differences in retention in care and viral suppression exist within Latino racial and birth
country subgroups, in order to identify areas for targeting interventions. Therefore, the objective of this
study was to identify potential disparities by race and by country of birth in retention in HIV care and
HIV viral load suppression, among Latinos with HIV. Furthermore, we sought to identify contributing
individual- and neighborhood-level risk factors unique to each racial and country of birth subgroup.
2. Data and Methods
2.1. Datasets
De-identified HIV surveillance records were obtained from the Florida Department of Health’s
(FDOH) enhanced HIV/AIDS reporting system (eHARS). Cases reported as Latino or Hispanic (of any
race), aged ≥ 13 years who met the Centers for Disease Control and Prevention (CDC) HIV case
definition [25] during the years 2000–2014, listed Florida as the most current state of residence, and
were alive at the end of 2015, were analyzed. Cases with missing or invalid data for the current ZIP
code (n = 2866), a reported current ZIP code with a population of zero based on American Community
Survey (ACS) estimates (n = 9), or those diagnosed in a correctional facility (n = 322), were excluded.
Latinos born in an “unknown/unspecified” or missing country of birth (n = 1746), or in countries
other than the U.S., Puerto Rico, Mexico, Cuba, Central America, and South America (n = 1001), were
also excluded. No cases were missing data on retention in HIV care or viral suppression during 2015.
The 2009–2013 American Community Survey (ACS) was used to obtain neighborhood-level data using
ZIP code tabulation areas (ZCTAs) [26]. ZCTAs are used by the U.S. Census Bureau to approximate
U.S. postal service ZIP codes for tabulating and reporting summary statistics [27].
2.2. Individual-Level Variables
Our primary individual-level variables of interest from eHARS were race and country of birth.
These data were self-reported during HIV testing, reported by a health care provider, or extracted from
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medical chart reviews. Our study included only individuals reported as being of Latino/Hispanic
ethnicity. Race was missing for 988 (8.2%) of the 12,106 Latinos who met our inclusion criteria.
We imputed data for race using the PROC MI procedure in SAS, by creating 10 datasets. We used the
year of HIV diagnosis, sex, age, country of birth, and HIV transmission mode, to predict race in a fully
conditional specification (FCS) model [28]. All analyses were fitted by imputation, by constructing
pooled estimates. Country of birth was missing for 1746 (9.3%) of all cases diagnosed between 2000
and 2014. Cases with a missing or unknown country of birth were excluded. Imputation was not
conducted in this case, due to the many countries in which individuals could have been born and
the limited individual-level data available for imputation. We grouped the country of birth into six
categories: U.S., Puerto Rico, Mexico, Cuba, Central America, and South America. The U.S.-born
category included individuals born in any of the 50 states, District of Columbia, or any U.S. dependent
territory, but excluded Puerto Rico. Central America included Costa Rica, El Salvador, Guatemala,
Honduras, Nicaragua, and Panama. South America included Argentina, Bolivia, Chile, Colombia,
Ecuador, Paraguay, Peru, Uruguay, and Venezuela.
Our outcomes of interest were also extracted from eHARS and included retention in HIV care
and HIV viral load suppression in 2015. Retention in care during 2015 was defined as evidence of
engagement in care two or more times, at least three months apart, during 2015. Engagement in care
was defined as evidence of at least one laboratory test, a prescription fill through the AIDS Drug
Assistance Program (ADAP) (for those in ADAP), or a physician visit documented in one of the
Ryan White databases (for those receiving services through the Ryan White HIV/AIDS program).
HIV viral load suppression during 2015 was also defined and calculated by the FDOH as having
evidence of a viral load <200 copies/mL in the last laboratory test, performed during 2015. The last
viral load test during the measurement year is used by the U.S. Department of Health and Human
Services’ HIV/AIDS Bureau to measure program performance [29]. Additionally, we extracted the
following individual-level data from eHARS: HIV diagnosis year, sex at birth, age at HIV diagnosis,
HIV transmission mode, AIDS diagnosis (if case progressed to AIDS by 31 December 2015), year of
death, and current residential ZIP code.
2.3. Neighborhood-Level Variables
Thirteen neighborhood-level socioeconomic status (SES) indicators were extracted from the ACS
to develop an SES index of Florida neighborhoods (ZCTAs). These indicators were selected based on
theoretical and empirical relevance, and covered a comprehensive range of domains, most commonly
used in previous studies. Details are provided in a previous publication by Niyonsenga and the
authors of the current study [30]. The thirteen indicators included were: percent of households without
access to a car, percent of households with ≥1 person per room, percent of population living below
the poverty line, percent of owner-occupied homes worth ≥$300,000, median household income in
2013, percent of households with annual income <$15,000, percent of households with annual income
≥$150,000, income disparity (derived from percent of households with annual income <$10,000 and
percent of households with annual income ≥$50,000), percent of population aged ≥25 with less than a
12th grade education, percent of population aged ≥25 with a graduate professional degree, percent
of households living in rented housing, percent of population aged ≥16 who were unemployed,
and percent of population aged ≥16 employed in high working class occupation (ACS occupation
group: “managerial, business, science, and arts occupations”). Income disparity was calculated as the
logarithm of 100 times the percent of households with annual income <$10,000, divided by the percent
of households with annual income ≥$50,000, and was used as a proxy for the Gini-coefficient [30].
All neighborhood-level indicators were coded so that higher scores corresponded to lower SES (higher
disadvantage); they were then standardized.
To calculate the SES index, we started by conducting a reliability analysis. The Cronbach’s alpha
for all 13 indicators was 0.93. We selected seven indicators based on the correlation of the indicator
with the total index (high correlation), and the Cronbach’s alpha if the item was deleted (low alpha).
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The seven indicators selected were: percent below poverty, median household income, percent of
households with annual income <$15,000, percent of households with annual income ≥$150,000,
income disparity, percent of population age ≥25 with less than a 12th grade education, and high-class
work. The resulting Cronbach’s alpha increased (0.94).
Second, we conducted a principal component analysis with and without varimax rotation, which
revealed one factor with an eigenvalue greater than one (5.14). This factor accounted for 73.49% of
the variance in the indicators. Because all of the factor loadings were high (between 0.80 and 0.93),
we retained all seven indicators. Finally, we added the standardized scores for the seven variables, and
categorized these scores into quartiles.
To categorize ZCTAs into rural or urban areas, we used Categorization C of Version 2.0 (University
of Washington, Washington, DC, USA) of the Rural-Urban Commuting Area (RUCA) codes, developed
by the University of Washington WWAMI Rural Research Center [31]. The percent of the area
population who identified as Hispanic/Latino (Latino ethnic density), was extracted from the ACS
and divided into three categories: <25%, 25–49%, and ≥50% [32,33].
2.4. Statistical Analyses
Individual- and neighborhood-level data were merged by matching the current ZIP code of
each case, with the ZIP code’s corresponding ZCTA. First, we compared individual-level and
neighborhood-level characteristics by country of birth (including race). Second, we compared outcomes
by race and by country of birth by estimating crude and adjusted odds ratios, and 95% confidence
intervals for non-retention in care during 2015 and non-viral suppression during 2015. Multi-level
(Level 1: individual; Level 2: neighborhood) logistic regression modeling was used to account for
correlation among cases living in the same neighborhood. To estimate the contribution of individual
and neighborhood factors on racial/ethnic disparities, we first estimated crude ORs (Model 1), followed
by ORs controlled for individual factors (Model 2), and ORs controlled for both individual and
neighborhood factors (Model 3). Finally, to identify unique predictors of non–retention in care and
non-viral suppression for each group, we estimated separate, fully adjusted models (Model 3), stratified
by country of birth. Odds ratios were calculated for the year of HIV diagnosis, race, sex, age, mode
of HIV transmission, AIDS diagnosis, neighborhood socioeconomic status (index of 7 indicators),
rural/urban status, and percent Latino in the neighborhood. SAS software, version 9.4 (SAS Institute,
Cary, NC 2002), was used to conduct analyses. The Florida International University Institutional
Review Board approved this study (IRB-13-0193), and the Florida Department of Health Institutional
Review Board designated this study as non-human subjects research.
3. Results
3.1. Characteristics of Participants
Of 18,793 Latinos diagnosed with HIV between 2000 and 2014 in Florida, 12,106 (64.4%) met our
inclusion/exclusion criteria. Most individuals were of White race (93.9%, includes imputed data for
race) (Table 1). U.S.-born Latinos accounted for the majority of cases (35.3%), followed by Latinos
born in Cuba (21.6%). A larger proportion of individuals born in Cuba were 50 years of age or older
(20.2%), when compared with individuals born in the U.S. (9.1%), Mexico (8.2%), and Central America
(9.1%). A larger proportion of individuals born in Cuba (75.7%) and South American (71.2%) reported
MSM as a potential mode of HIV transmission, when compared with fewer than 50% for those born
in Mexico and Central America. Individuals born in South America were less likely to live in a
neighborhood with low SES (26.6%), than those born in Central America (53.6%), Mexico (49.2%),
and Cuba (46.4%). Finally, nearly 65% of those born in Cuba lived in a neighborhood in which the
majority of the population was Latino.
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Table 1. Latinos age 13 and older diagnosed with HIV infection by birth country/region and selected
characteristics, Florida, 2000–2014.
All Latinos a
United
States-Born
Latinos
Puerto
Rico Mexico Cuba
Central
America b
South
America c
Total (n) 12,106 4276 1153 842 2618 1284 1933
Individual-Level Variables
Year of HIV diagnosis
2000–2003 3007 (24.8) 954 (22.3) 341 (29.6) 254 (30.2) 527 (20.1) 309 (24.1) 622 (32.2)
2004–2007 3291 (27.2) 1204 (28.2) 286 (24.8) 266 (31.6) 605 (23.1) 408 (31.8) 522 (27.0)
2008–2011 3158 (26.1) 1233 (28.8) 290 (25.2) 189 (22.5) 679 (25.9) 354 (27.6) 413 (21.4)
2012–2014 2650 (21.9) 885 (20.7) 238 (20.5) 133 (15.8) 807 (30.8) 213 (16.6) 376 (19.5)
Race d
Black 740 (6.1) 416 (9.7) 76 (6.6) 12 (1.4) 118 (4.5) 80 (6.1) 38 (2.0)
White 11,366 (93.9) 3860 (90.3) 1077 (93.4) 830 (98.6) 2500 (95.5) 1204 (93.8) 1895 (98.0)
Sex at birth
Male 9997 (82.6) 3352 (78.4) 878 (76.2) 727 (86.3) 2388 (91.2) 983 (76.6) 1669 (86.3)
Female 2109 (17.4) 924 (21.6) 275 (23.9) 115 (13.7) 230 (8.8) 301 (23.4) 264 (13.7)
Age at diagnosis
13–24 1630 (13.5) 865 (20.2) 125 (10.8) 125 (14.9) 205 (7.8) 157 (12.2) 153 (7.9)
25–49 8969 (74.1) 3023 (70.7) 840 (72.9) 648 (77.0) 1884 (72.0) 1010 (78.7) 1564 (80.9)
50 or older 1507 (12.5) 388 (9.1) 188 (16.3) 69 (8.2) 529 (20.2) 117 (9.1) 216 (11.2)
Mode of transmission
IDU 860 (7.1) 392 (9.2) 233 (20.2) 41 (4.9) 89 (3.4) 44 (3.4) 61 (3.2)
MSM 7434 (61.4) 2506 (58.6) 526 (45.6) 413 (49.1) 1983 (75.7) 630 (49.1) 1376 (71.2)
Heterosexual 2901 (24.0) 1026 (24.0) 304 (26.4) 266 (31.6) 438 (16.7) 483 (37.6) 384 (19.9)
Other
unknown 911 (7.5) 352 (8.2) 90 (7.8) 122 (14.5) 108 (4.1) 127 (9.9) 112 (5.8)
AIDS
No 6906 (57.1) 2527 (59.1) 640 (55.5) 370 (43.9) 1633 (62.4) 586 (45.6) 1150 (59.5)
Yes 5200 (43.0) 1749 (40.9) 513 (44.5) 472 (56.1) 985 (37.6) 698 (54.4) 783 (40.5)
ZCTA-Level Variables
SES index, quartiles
1 (lowest) 4786 (39.5) 1532 (35.8) 424 (36.8) 414 (49.2) 1214 (46.4) 688 (53.6) 514 (26.6)
2 2825 (23.3) 1048 (24.5) 324 (28.1) 191 (22.7) 574 (21.9) 238 (18.5) 450 (23.3)
3 3001 (24.8) 1094 (25.6) 265 (23.0) 161 (19.1) 625 (23.9) 240 (18.7) 616 (31.9)
4 (highest) 1494 (12.3) 602 (14.1) 140 (12.1) 76 (9.0) 205 (7.8) 118 (9.2) 353 (18.3)
RUCA Classification
Urban 11,870 (98.1) 4180 (97.8) 1123 (97.4) 785 (93.2) 2596 (99.2) 1279 (99.2) 1922 (99.4)
Rural 236 (2.0) 96 (2.3) 30 (2.6) 57 (6.8) 22 (0.8) 22 (0.8) 11 (0.6)
Percent of population Hispanic
≥50 4694 (38.8) 1196 (28.0) 296 (25.7) 206 (24.5) 1697 (64.8) 562 (43.8) 737 (38.1)
25–49 3858 (31.9) 1429 (33.4) 402 (34.9) 274 (32.5) 640 (24.5) 382 (29.8) 731 (37.8)
<25 3554 (29.4) 1651 (38.6) 455 (39.5) 362 (43.0) 281 (10.7) 340 (26.5) 465 (24.1)
HIV, human immunodeficiency virus; IDU, injection drug use; MSM, male to male sexual contact; ZCTA, zip code
tabulation area; SES, socioeconomic status. Percentage may not add up to 100 due to rounding. a Excludes cases
diagnosed in a correctional facility (n = 322), missing current residential zip code (n = 2866) or had a reported zip code
with an American Community Survey population of zero (n = 9), diagnosed under the age of 13 (n = 67), died before
the year 2016 (n = 2751), and whose current state of residence was not Florida (n = 1077) or was missing (n = 407).
Latinos born in an “unknown/unspecified” or missing country of birth (n = 1746) or in countries other than the U.S.,
Puerto Rico, Mexico, Cuba, Central America, and South America (n = 1001) were also excluded. b Includes Latinos
born in Costa Rica (n = 56), El Salvador (n = 111), Guatemala (n = 245), Honduras (n = 496), Nicaragua (n = 299), and
Panama (n = 77). c Includes Latinos born in Argentina (n = 278), Bolivia (n = 17), Chile (n = 78), Colombia (n = 672),
Ecuador (n = 92), Paraguay (n = 18), Peru (n = 245), Uruguay (n = 50), and Venezuela (n = 483). d Race was missing
for 988 Latinos that met our inclusion/exclusion criteria. After multiple imputation, 60 individuals were from a race
other than Black or White (American Indian/Alaskan Native = 33, Asian = 14, Native Hawaiian/Pacific Islander = 13)
and were excluded.
3.2. Retention in HIV Care
Overall, 31.9% of Latinos in our study were not retained in HIV care in 2015. The proportion
of Latinos not retained in care by race, was similar (Black 33.9%, White 31.7%) (Table 2). Models
adjusting for individual- and neighborhood-level factors showed similar non-significant results for
non–retention in care by race. The proportion of Latinos who were born in Mexico (49.3%) and Central
America (38.7%), who were not retained in care, was significantly higher than for Latinos born in the
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U.S. (32.7%). Differences remained significant after controlling for individual- and neighborhood-level
factors (Mexico adjusted (aOR) 2.00, 95% confidence interval (CI) 1.70–2.36; Central America aOR 1.33,
95% CI 1.16–1.53). Within the Central America group, only those born in Guatemala (aOR 2.39, 95%CI
1.80–3.18) and Honduras (aOR 1.39, 95% CI 1.13–1.72) had significantly higher odds of non-retention
in care, when compared with U.S.-born Latinos. More than 50% of Latinos born in Guatemala (53.2%)
were not retained in HIV care. For both Mexican-born and Central American-born Latinos, being male
was a risk factor (Mexico aOR 1.93, 95% CI 1.16–3.21; Central America aOR 2.47, 95% CI 1.73–3.55; not
in table), as was not having AIDS (Mexico aOR 1.81, 95% CI 1.32–2.49; Central America 1.49, 95% CI
1.16–1.91, not in Table), for non-retention in care.
Table 2. Differences in non-retention in HIV care in 2015 by Black-White race and country of birth
among Latinos aged 13 years and older diagnosed with HIV 2000–2014 in Florida.
Model 1 Model 2 Model 3
All Latinos Total, n Not retained incare, n (%)
Crude OR for
non-retention
in care (95% CI)
Adjusted OR for
non-retention in
care (95% CI)
Adjusted OR for
non-retention in
care (95% CI)
Race
Black 740 251 (33.9) 1.11 (0.94–1.29) 1.08 (0.92–1.28) 1.11 (0.93–1.31)
White 11,366 3605 (31.7) Referent Referent Referent
Country of birth
United States 4276 1399 (32.7) Referent Referent Referent
Puerto Rico 1153 377 (32.7) 1.00 (0.87–1.15) 0.99 (0.85–1.14) 1.00 (0.86–1.16)
Mexico 842 415 (49.3) 2.00 (1.72–2.32) 1.99 (1.70–2.33) 2.00 (1.70–2.36)
Cuba 2618 493 (18.8) 0.48 (0.43–0.54) 0.54 (0.48–0.61) 0.52 (0.45–0.59)
Central America 1284 497 (38.7) 1.30 (1.14–1.48) 1.38 (1.20–1.58) 1.33 (1.16–1.53)
South America 1933 675 (34.9) 1.10 (0.99–1.24) 1.17 (1.04–1.32) 1.11 (0.98–1.26)
Central
American and
U.S. born
Total, n Not retained incare, n (%)
Crude OR for
non-retention
in care (95% CI)
Adjusted OR for
non-retention in
care (95% CI)
Adjusted OR for
non-retention in
care (95% CI)
Country of birth
United States 4276 1399 (32.7) Referent Referent Referent
Costa Rica 56 22 (39.3) 1.33 (0.78–2.28) 1.37 (0.78–2.40) 1.36 (0.77–2.24)
Guatemala 248 132 (53.2) 2.34 (1.81–3.03) 2.44 (1.85–3.22) 2.39 (1.80–3.18)
Honduras 496 197 (39.7) 1.36 (1.12–1.64) 1.44 (1.18–1.76) 1.39 (1.13–1.72)
Nicaragua 299 90 (30.1) 0.89 (0.69–1.14) 0.99 (0.76–1.29) 0.94 (0.71–1.23)
Panama 77 21 (27.3) 0.77 (0.47–1.28) 0.89 (0.53–1.51) 0.90 (0.53–1.52)
El Salvador 111 38 (34.2) 1.07 (0.72–1.59) 1.03 (0.68–1.57) 1.03 (0.67–1.57)
OR, odds ratio; CI, confidence interval; Model 1: Crude rates; Model 2: Controlling for individual-level variables;
Model 3: Controlling for individual-level variables and neighborhood-level variables.
3.3. Viral Suppression
Overall, 35.9% of Latinos in our study were not virally suppressed in 2015. A larger proportion
of Black Latinos (40.4%) were not virally suppressed, when compared with White Latinos (35.6%)
(crude OR 1.23, 95% CI 1.05–1.43) (Table 3). The difference in the odds of non-viral suppression
between Blacks and Whites remained after adjusting for individual–level variables, including country
of birth (aOR 1.19, 95% CI 1.04–1.37), but not after controlling for both individual and neighborhood
factors (aOR 1.16, 95% CI 0.98–1.36). Similar to retention in care, Latinos born in Mexico (52.7%) and
Central America (43.3%) were more likely not to be virally suppressed when compared with U.S.-born
Latinos (37.3%). These differences remained after controlling for individual and neighborhood factors
(Mexico aOR 1.85, 95% CI 1.57–2.17; Central America aOR 1.28, 95% CI 1.12–1.47). Further examination
of Central America showed that only Latinos born in Guatemala (aOR 2.20, 95% CI 1.66–2.92) and
Honduras (aOR 1.42, 95% CI 1.16–1.74) had an elevated risk when compared with U.S.-born Latinos.
Similar to non-retention in care, Latinos born in Mexico who were male, were at increased odds of
non-viral suppression compared to their female counterparts (aOR 1.77, 95% CI 1.08–2.29), as were
people who had not been diagnosed with AIDS (aOR 1.65, 95% CI 1.21–2.25) (not in Table). For Central
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American-born Latinos, being male (aOR 1.94, 95% CI 1.36–2.75), reporting injection drug use when
compared with heterosexual contact (aOR 2.06, 95% CI 1.03–4.13), and not having AIDS (aOR 1.42,
95% CI 1.11–1.81), were all risk factors for non-viral suppression. The HIV transmission mode of MSM,
when compared with heterosexual contact, was protective for those born in Central America (aOR
0.59, 95% CI 0.43–0.82).
Table 3. Differences in HIV non-viral load suppression (<200copies/mL) in 2015 by Black-White race
and country of birth among Latinos aged 13 years and older diagnosed with HIV 2000–2014 in Florida.
Model 1 Model 2 Model 3
All Latinos Total, n Not virallysuppressed, n (%)
Crude OR for
non-viral
suppression (95% CI)
Adjusted OR for
non-viral
suppression (95% CI)
Adjusted OR for
non-viral
suppression (95% CI)
Race
Black 740 299 (40.4) 1.23 (1.05–1.43) 1.19 (1.04–1.37) 1.16 (0.98–1.36)
White 11366 4049 (35.6) Referent Referent Referent
Country of birth
United States 4276 1595 (37.3) Referent Referent Referent
Puerto Rico 1153 437 (37.9) 1.03 (0.90–1.17) 1.02 (0.89–1.17) 1.02 (0.89–1.18)
Mexico 842 444 (52.7) 1.88 (1.62–2.18) 1.87 (1.60–2.19) 1.85 (1.57–2.17)
Cuba 2618 595 (22.7) 0.50 (0.44–0.55) 0.58 (0.52–0.66) 0.56 (0.50–0.64)
Central America 1284 556 (43.3) 1.28 (1.13–1.46) 1.36 (1.19–1.55) 1.28 (1.12–1.47)
South America 1933 721 (37.3) 1.00 (0.90–1.12) 1.10 (0.98–1.24) 1.07 (0.95–1.21)
Central
American and
U.S. born
Total, n Not virallysuppressed, n (%)
Crude OR for
non-viral
suppression (95% CI)
Adjusted OR for
non-viral
suppression (95% CI)
Adjusted OR for
non-viral
suppression (95% CI)
Country of birth
United States 4276 1595 (37.3) Referent Referent Referent
Costa Rica 56 23 (41.1) 1.17 (0.69–2.00) 1.28 (0.74–2.22) 1.25 (0.71–2.18)
Guatemala 248 141 (56.9) 2.22 (1.71–2.89) 2.29 (1.74–3.07) 2.20 (1.66–2.92)
Honduras 496 227 (45.8) 1.41 (1.18–1.71) 1.52 (1.25–1.85) 1.42 (1.16–1.74)
Nicaragua 299 103 (34.5) 0.88 (0.69–1.13) 1.01 (0.78–1.30) 0.94 (0.73–1.23)
Panama 77 22 (28.6) 0.67 (0.41–1.11) 0.78 (0.47–1.30) 0.77 (0.46–1.29)
El Salvador 111 43 (38.7) 1.06 (0.72–1.57) 1.06 (0.71–1.58) 1.03 (0.68–1.54)
OR, odds ratio; CI, confidence interval; Model 1: Crude rates; Model 2: Controlling for individual-level variables;
Model 3: Controlling for individual-level variables and neighborhood-level variables.
4. Discussion
Our study has three primary findings. First, our study suggests no significant racial differences
in non-retention in HIV care between Black and White Latinos, and only marginal racial differences
in non-viral suppression that appear to be explained by differences in individual and neighborhood
characteristics. Second, Latinos born in Mexico and Central America were at increased odds of
non-retention in care and non-viral suppression when compared with U.S.-born Latinos, even after
controlling for individual- and neighborhood-level factors. Those born in Guatemala and Honduras
were particularly at risk. Finally, among Mexican-born and Central American-born Latinos, being
male nearly doubled the odds of non-retention in care and non-viral suppression.
We did not find racial disparities in retention in HIV care among Latinos in our study. Although
this is the first study to examine retention in HIV care among Latinos by race, we expected to find
significant differences given the racial disparities in retention seen among non-Latinos [8,34–37].
Our findings are also inconsistent with reports suggesting that Black Latinos resemble non-Latino
Blacks in access to care [38]. Furthermore, racial disparities among Latinos have been documented
in delayed HIV diagnosis [15], and in non-HIV related outcomes, including birth outcomes [39].
Our study did show marginally significant disparities in viral load suppression, with Black Latinos
exhibiting increased odds of non–viral suppression. This difference remained after controlling for
year of diagnosis, sex, age, HIV transmission mode, and country of birth, suggesting that these
individual-level variables did not explain the disparities. However, the effect of race on non-viral
suppression disappeared after controlling for individual factors and neighborhood socioeconomic
status, rural/urban residence, and Latino ethnic density. This may reflect the fact that Black Latinos
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experience higher poverty and unemployment, and lower educational attainment, when compared
with White Latinos [17].
Latinos born in Mexico in our study had a two-fold increase in odds of non-retention in care and
non-viral suppression, when compared with U.S.-born Latinos. Similar but less pronounced effects
were seen among Latinos born in Central America. While these results are not consistent with a study
of Latinos recruited in five Los Angeles HIV clinics [16], they are consistent with numerous studies
reporting disparities in delayed HIV diagnoses [10–12], and survival [10,13–15] among these groups.
It is worth noting that the study in Los Angeles had a relatively small sample of individuals born in
Mexico (n = 109) and Central America (n = 36), and compared these groups with U.S.–born Latino and
African American MSM and women [16]. Our study further identified Latinos born in Guatemala and
Honduras as being at high risk. Also worth mentioning is the significant and protective effect of being
born in Cuba, when compared with the U.S., for both retention in HIV care and viral suppression.
These findings, and the fact that we did not find significant disparities by race, suggest that inequalities
may be due to cultural differences, differences in health seeking behavior, and possible differences in
immigration experience between Latinos born in Guatemala and Honduras, and U.S.–born Latinos.
For example, a qualitative study of Central American- and Mexican-born Latinos living with HIV
found that cultural factors, including gender roles and machismo, played a role in health care utilization.
Individuals also reported a fear of being deported if they sought care [40]; a fear more likely applicable
to Mexican- and Central American-born Latinos than Cuban-born Latinos due to differential U.S.
immigration policies. Acculturation also plays a role in health-seeking behavior among Latinos.
For example, a study of 219 Latinos with HIV (70% from Mexico and 24% from Central America), who
were not fully engaged in HIV care or were at risk of falling out of care, found that less acculturated
Latinos (whose primary language was Spanish) were more likely to experience stigma, belief, and
structural barriers to care than their more acculturated English-speaking counterparts [41]. They also
reported the tendency to seek care only when sick, because they are typically more concerned about
making ends meet for their children. This could explain why not having AIDS was a risk factor for
both retention in care and viral suppression.
Finally, our study found males to be at increased odds of non-retention in care and non-viral
suppression among Latinos born in Central America, Mexico, and South America, but not among
U.S.-born Latinos. Although we were unable to run the full multilevel models on Latinos born in
Guatemala and Honduras due to the smaller size of these groups, we were able to do some exploratory
analyses. Models adjusting for individual–level factors only, suggested that males born in Guatemala
were almost three times more likely not to be retained in care or be virally suppressed, when compared
with their female counterparts (aOR 2.82, 95% CI 1.24–6.42; 2.82, 95% CI 1.23–6.42, respectively).
Males born in Honduras were also at increased risk compared with females born in Honduras, for
retention in care only (aOR 2.22, 95% CI 1.31–3.78). Our finding of lower retention in care and viral
suppression among males is consistent with the literature [36,42–45], although a few studies have found
males to be more likely to be virally suppressed [44], or have found no differences by gender [35]. It is
possible that males born in these countries traveled to the U.S. alone, either as migrant workers, or to
work permanently in the U.S. to provide for a family member in their home country. Participants of a
qualitative study of HIV-infected Mexican, Central American, and Dominican immigrants, expressed
that men who do not have families in the U.S. will not seek care because women typically make them
go or increase the urgency of seeking care [40].
Our study has four main limitations. First, Latinos in our surveillance dataset who do not have
evidence of being engaged in care may be getting care outside of the U.S. This data limitation is
more likely among foreign-born Latinos. Related to this, our study assumes that Latinos not engaged
in care are not virally suppressed. Second, data on race and country of birth was self-reported or
abstracted from medical records. While country of birth is more objective, Latinos have reported
being unclear or undefined about their racial category [46]. Third, we lacked data on ethnic origin for
U.S.-born Latinos. Therefore, our discussion of ethnic and cultural differences between Latinos born in
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various countries/regions and U.S.-born Latinos is limited, and effect sizes seen in our study may be
underestimated, depending on the ethnic origin distribution of our U.S.-born population. Additionally,
the relatively small size of our population of Latinos born in Guatemala and Honduras prevented
us from being able to conduct multilevel models to identify neighborhood-level risk factors for
non-retention in care and non-viral suppression in these groups. Finally, our surveillance data lacked
important information on individual-level socioeconomic status, years in the U.S. for foreign-born
Latinos, health insurance status, and antiretroviral therapy.
5. Conclusions
Our study identified significant disparities in retention in HIV care and viral load suppression
among Mexican- and Central American-born Latinos. These disparities may explain the large
differences in survival after HIV diagnosis among Latinos reported in numerous previous studies.
The individual and neighborhood factors we examined in this study did not account for the disparities
we found, and thus further studies may be needed to examine the mechanisms for these inequalities.
Nevertheless, HIV clinics and providers must be aware of the increased risk of non-retention in care
and non-viral suppression among these Latino groups when serving this community, and consider
the implementation of culturally targeted health service strategies. Our study also suggests that male
Latinos born in Mexico and Central America, particularly those born in Guatemala and Honduras,
are at greatest risk. Decreasing barriers to care for Latino men, particularly those affecting men
with low socioeconomic status, such as offering extended and weekend clinic hours, may need to
be considered. Our study provides a clear rationale for studying Latinos by racial and country of
birth subgroups, and it highlights the need for tailoring interventions to the unique healthcare and
treatment barriers of each of these populations.
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